β4 Integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer

Modern Pathology

Volumn 18, Issue 9, 2005, Pages 1165-1175

  Diaz, Leslie K ^a   Cristofanilli, Massimo ^a   Zhou, Xiao ^a   Welch, Kristin L ^a   Smith, Terry L ^a   Yang, Ying ^a   Sneige, Nour ^a   Sahin, Aysegul A ^a   Gilcrease, Michael Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

6 4 integrin; In situ hybridization; Laminin 5

Indexed keywords

ALPHA6BETA4 INTEGRIN; KALININ; MESSENGER RNA; CELL ADHESION MOLECULE; PROTEIN SUBUNIT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; BIOSYNTHESIS; BREAST TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTEGRIN ALPHA6BETA4; MIDDLE AGED; PROGNOSIS; PROTEIN SUBUNITS; RETROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 30544433712     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800411     Document Type: Article

References (45)

1. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
2. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-10874.
3. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423.
4. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98:11462-11467.
5. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
6. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
7. Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol 1998;8:359-364.
8. Clarke AS, Lotz MM, Mercurio AM. A novel structural variant of the human beta 4 integrin cDNA. Cell Adhes Commun 1994;2:1-6.
9. Hogervorst F, Kuikman I, von dem Borne AE, et al. Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118kd cytoplasmic domain. EMBO J 1990;9:765-770.
10. Suzuki S, Naitoh Y. Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells. EMBO J 1990;9:757-763.
11. Tamura RN, Rozzo C, Starr L, et al. Epithelial integrin alpha 6 beta 4: complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol 1990;111:1593-1604.
12. Iacovacci S, Gagnoux-Palacios L, Zambruno G, et al. Genomic organization of the human integrin beta4 gene. Mamm Genome 1997;8:448-450.
13. Pulkkinen L, Kurtz K, Xu Y, et al. Genomic organization of the integrin beta 4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab Invest 1997;76:823-833.
14. van Leusden MR, Kuikman I, Sonnenberg A. The unique cytoplasmic domain of the human integrin variant beta4E is produced by partial retention of intronic sequences. Biochem Biophys Res Commun 1997;235:826-830.
15. Shaw LM. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 2001;21:5082-5093.
16. Shaw LM, Rabinovitz I, Wang HH, et al. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 1997;91:949-960.
17. Rabinovitz I, Mercurio AM. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol 1997;139:1873-1884.
18. Rabinovitz I, Toker A, Mercurio AM. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J Cell Biol 1999;146:1147-1160.
19. Rabinovitz I, Gipson IK, Mercurio AM. Traction forces mediated by alpha6beta4 integrin: implications for basement membrane organization and tumor invasion. Mol Biol Cell 2001;12:4030-4043.
20. Chung J, Bachelder RE, Lipscomb EA, et al. Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 2002;158:165-174.
21. O'Connor KL, Nguyen BK, Mercurio AM. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J Cell Biol 2000;148:253-258.
22. Tagliabue E, Ghirelli C, Squicciarini P, et al. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 1998;4:407-410.
23. Davis TL, Cress AE, Dalkin BL, et al. Unique expres sion pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001;46:240-248.
24. Diaz LK, Zhou X, Welch K, et al. Chromogenic in situ hybridization for alpha6beta4 integrin in breast cancer: correlation with protein expression. J Mol Diagn 2004;6:10-15.
25. Leary JJ, Brigati DJ, Ward DC. Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots. Proc Natl Acad Sci USA 1983;80:4045-4049.
26. Radinsky R, Bucana CD, Ellis LM, et al. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 1993;53:937-943.
27. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-1709.
28. Gambaletta D, Marchetti A, Benedetti L, et al. Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 2000;275:10604-10610.
29. Mainiero F, Pepe A, Yeon M, et al. The intracellular functions of alpha6beta4 integrin are regulated by EGF. J Cell Biol 1996;134:241-253.
30. Mukhopadhyay R, Theriault RL, Price JE. Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 1999;17:325-332.
31. O'Connor KL, Shaw LM, Mercurio AM. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J Cell Biol 1998;143:1749-1760.
32. Mainiero F, Murgia C, Wary KK, et al. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 1997;16:2365-2375.
33. Klemke RL, Cai S, Giannini AL, et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997;137:481-492.
34. Nagato T, Yoshida H, Yoshida A, et al. A scanning electron microscope study of myoepithelial cells in exocrine glands. Cell Tissue Res 1980;209:1-10.
35. Tavassoli FA. Myoepithelial lesions of the breast. Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol 1991;15:554-568.
36. Schnitt SJ, Silen W, Sadowsky NL, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988;318:898-903.
37. Silverberg SG, Chitale AR. Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer 1973;32:830-837.
38. Martin KJ, Kwan CP, Nagasaki K, et al. Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 1998;4:602-613.
39. de Melker AA, Sonnenberg A. Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events. Bioessays 1999;21:499-509.
40. Hogervorst F, Kuikman I, van Kessel AG, et al. Molecular cloning of the human alpha 6 integrin subunit. Alternative splicing of alpha 6 mRNA and chromosomal localization of the alpha 6 and beta 4 genes. Eur J Biochem 1991;199:425-433.
41. Delwel GO, Kuikman I, Sonnenberg A. An alternatively spliced exon in the extracellular domain of the human alpha 6 integrin subunit - functional analysis of the alpha 6 integrin variants. Cell Adhes Commun 1995;3:143-161.
42. Tamura RN, Cooper HM, Collo G, et al. Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc Natl Acad Sci USA 1991;88:10183-10187.
43. Micheloni A, Falcioni R, Zambruno G, et al. The human integrin beta4B and beta4C variants are not expressed in a tissue-specific manner. FEBS Lett 2002;519:238-239.
44. Tandon AK, Clark GM, Chamness GC, et al. HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989;7:1120-1128.
45. Gusterson BA, Gelber RD, Goldhirsch A, et al. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992;10:1049-1056.